Clinical Trials Browser

Phase EARLY_PHASE1 × Interventional × osimertinib × Clear all

NCT03755102 2025-05-15

A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.

Phase EARLY_PHASE1 Completed

Lung Neoplasms

NCT06557096 2024-08-16

CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC

Phase EARLY_PHASE1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating